FDA Drug Application (017661) for TAVIST-1 by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number017661
Product Number002
FormTABLET;ORAL
Dosage1.34MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTAVIST-1
Active IngredientCLEMASTINE FUMARATE

Active IngredientCount
List of drugs with Active Ingredient CLEMASTINE FUMARATE4


Back to FDA Applications sponsored by NOVARTIS